Introduction {#s1}
============

Individual risk factors associated with pneumococcal disease include increasing age, presence of chronic respiratory and/or heart disease, cigarette smoking, immunosuppression and child contact \[[@C1]--[@C5]\]. At a population level, winter months in temperate regions are associated with an increased incidence of both invasive pneumococcal disease (IPD) and non-bacteraemic community-acquired pneumonia (CAP) \[[@C6]--[@C10]\]. Although poorly understood, this association has been attributed to 1) environmental factors such as humidity, temperature, photoperiod and geographical location, *e.g.* latitude \[[@C7], [@C8]\]; 2) host factors such as vitamin D and melatonin levels \[[@C11], [@C12]\]; and 3) pathogen factors, such as respiratory viral co-infection \[[@C13], [@C14]\]. However, studies assessing temporal changes of pneumococcal disease often use aggregate time periods such as seasons and, as a consequence, may contribute to a type of ecological fallacy in which the effects of other subsets of clinically significant exposures are neglected \[[@C12]\]. Changes in human behaviour and school holiday periods have been demonstrated to have an impact on influenza transmission \[[@C15], [@C16]\]. In contrast, despite the recognised association between child contact and adult pneumococcal disease \[[@C5]\], there have been no studies to date assessing the relationship between school holiday periods and hospitalisation with noninvasive pneumococcal CAP in adults.

School holiday periods fundamentally alter child contact patterns. Children not only have less contact with other school-age children, but have more adult close contact as a consequence of alterations in childcare arrangements, vacations and family gatherings \[[@C17], [@C18]\]; this can be expected to affect disease transmission. We hypothesised that changes in child contact patterns during school holiday periods would result in an increase in adult noninvasive pneumococcal CAP during these periods.

Methods {#s2}
=======

Study design {#s2a}
------------

Between September 2008 and September 2013, we conducted a prospective cohort study of consecutive patients with CAP admitted to two teaching hospitals in Nottingham. Combined, these two hospitals cover the catchment area for acute and emergency admissions in the Greater Nottingham area. Adults \>16 years were included if they presented with symptoms of a lower respiratory tract infection (at least one of cough, increasing breathlessness, sputum production and fever), had radiographic infiltrates consistent with respiratory infection, and were treated by their clinical team for a diagnosis of CAP. Patients who had been hospitalised in the preceding 10 days or who had a diagnosis of either post-obstructive pneumonia (*e.g.* from an obstructive bronchogenic tumour) or tuberculosis were excluded. Patient demographics and clinical details were collected by the study team after informed consent was obtained. In the event that patients lacked capacity, patient personal consultees were approached for assent for study inclusion. All study procedures were approved by Nottingham Research Ethics Committee.

Study population {#s2b}
----------------

Urine samples were taken on admission from each individual for microbiological analysis: a BinaxNOW® Urine Antigen Detection (UAD) assay (Alere Scarborough, Inc., Scarborough, ME, USA) was performed for pneumococcal C-polysaccharide antigen detection in the local microbiological laboratories whilst the remaining volume of urine was frozen and batch transported to Public Health England\'s Respiratory and Vaccine Preventable Bacteria Reference Laboratory in Colindale for detection of pneumococcal serotype-specific antigen by a multiplex immunoassay (Bio-Plex). The sensitivity and specificity for pneumococcal detection using the BinaxNOW® method are 74% and 97%, respectively, and for the Bio-Plex method are 79% and 99%, respectively \[[@C19], [@C20]\]. Isolates of *Streptococcus pneumoniae* from bacteraemic cases were serotyped by slide agglutination using Statens Serum sera (Statens Serum Institut, Copenhagen, Denmark). Patients were defined as having pneumococcal CAP if 1) pneumococcal urinary antigen was detected, 2) pneumococcal serotype was detected by the Bio-Plex assay, or 3) *S. pneumoniae* was isolated and serotyped from blood cultures. Data regarding child contact (defined as ≤16 years of age) in the 4 weeks prior to admission were obtained from all study patients (see supplementary material). Individuals were considered to have had meaningful child contact if any one of the following applied: household contact with a child, kissing or cuddling a child, cumulative child contact for ≥8 h over the prior 4 weeks, and/or those whose occupation involved childcare (*e.g.* day-care workers, teachers). School holiday and term time dates for the corresponding years were obtained from Nottingham City and County Council records. Population demographics for the Greater Nottingham Area were derived from the UK national census data (2011) \[[@C21]\].

Statistical considerations {#s2c}
--------------------------

Statistical analyses were performed using Stata/IC 13.1 (StataCorp., College Station, TX, USA). Baseline characteristics and risk factors associated with pneumococcal disease of adults admitted during school holiday periods and term time were compared for categorical variables using Pearson\'s Chi-squared or Fisher\'s tests. The following variables were included: age, sex, active malignancy, chronic liver disease, congestive cardiac failure, dementia, diabetes, chronic renal disease, alcohol excess, cerebrovascular disease, admission from a care facility, HIV diagnosis, smoking status, chronic obstructive airway disease (COPD), asthma, severity of pneumonia (by CURB65 criteria; one point scored for each of new onset confusion, serum urea \>7 mmol·L^−1^, respiratory rate ≥30·min^−1^, systolic blood pressure \<90 mmHg or diastolic blood pressure ≤60 mmHg, age ≥65 years) and child contact status. The independent association between admission during school holidays and diagnosis of CAP of pneumococcal compared to non-pneumococcal aetiology was examined using a multivariable logistic regression model. The included variables in the final model were those significantly associated with a diagnosis of pneumococcal CAP and/or that led to a \>10% change in the regression co-efficient; likelihood ratio tests were used to accurately fit continuous variables. Seasons were grouped by meteorological definitions: winter (December--February), spring (March--May), summer (June--August) and autumn (September--November). Serotypes were grouped into pneumococcal conjugate vaccine (PCV)-7 types (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F), additional PCV-13 types (serotypes 1, 3, 5, 6A/C, 7F/A, 19A) and "other" non-PCV-13 serotypes. A sensitivity analysis was performed to account for the effect of winter by comparing outcomes with the inclusion and exclusion of winter months, for the effect of child contact by excluding individuals that worked with children and those who had no preceding child contact, and for the effect of age by excluding older individuals (defined as those ≥65 years). Daily and weekly incidence rates were calculated and differences in incidence of all-cause, non-pneumococcal and pneumococcal CAP requiring hospital admission in school holiday periods *versus* term time were compared using a Poisson regression model.

Results {#s3}
=======

Study population {#s3a}
----------------

During the study period, 2702 individuals met the eligibility criteria; of these, 284 patients had an alternative final diagnosis and consent was not obtained from a further 194 individuals. In an additional three patients, admission dates fell outside the 5-year study period, leaving 2221 patients for analysis. As is characteristic in the UK, school holiday periods in the Greater Nottingham Area were composed of six main holidays over each academic year. Over the 5 years of the study, a total of 465 days were school holidays. The summer season encompassed 224 holiday days (48.2%) compared to 119 days (25.6%) over the winter season.

Baseline characteristics {#s3b}
------------------------

The median age of the study population was 71 years (interquartile range (IQR) 56--80  years); 55.1% were male. In total, 575 individuals (25.9%) were admitted during school holiday periods. Pneumococcal CAP was diagnosed in 643 out of 2221 individuals (29.0%). The diagnosis of pneumococcal disease was made by blood culture, BinaxNOW® UAD and Bio-Plex positivity in 82 out 643 cases (12.8%), 399 out of 643 cases (62.1%) and 403 out of 643 cases (62.7%), respectively. Admissions over the winter season accounted for 274 (42.6%) of pneumococcal CAP cases.

The effect of school holiday periods on pneumococcal community-acquired pneumonia {#s3c}
---------------------------------------------------------------------------------

Those admitted to hospital during school holiday periods were significantly more likely to have a diagnosis of pneumococcal CAP compared to those admitted during term time (35.3% *versus* 26.7%; OR 1.50, 95% CI 1.22--1.83, p\<0.001). In patients with pneumococcal CAP, there was no difference in baseline demographics or disease severity at admission between those admitted during the school holiday periods compared to those admitted during term time. Whilst fewer patients with obstructive airway diseases were admitted during school holiday periods, no differences in other co-morbid conditions were noted between school holiday periods and term time ([table 1](#TB1){ref-type="table"}). Individuals admitted during school holidays were significantly more likely to report child contact in the preceding month (42.0% during school holiday periods *versus* 33.7% during term time; OR 1.43, 95% CI 1.00--2.03, p=0.046).

###### 

Baseline characteristics of adults admitted with pneumococcal community-acquired pneumonia during school holiday periods *versus* term time

                                              **Admission during school holiday**   **Admission during term time**    **OR (95% CI)**     **p-value**
  ------------------------------------------ ------------------------------------- -------------------------------- -------------------- -------------
  **Subjects n**                                              203                                440                                     
  **Age years**                                                                                                                          
   16--49                                                  57 (28.1)                          100 (22.7)                 Reference         0.306^\#^
   50--64                                                  35 (17.2)                          74 (16.8)              0.83 (0.49--1.39)   
   65--74                                                  32 (15.8)                          97 (22.1)              0.58 (0.34--0.97)   
   75--84                                                  50 (24.6)                          99 (22.5)              0.89 (0.55--1.42)   
   ≥85                                                     29 (14.3)                          70 (15.9)              0.73 (0.42--1.25)   
  **Male**                                                104 (51.2)                          217 (49.3)             1.08 (0.77--1.51)       0.652
  **Care home resident**                                    7 (3.5)                            21 (4.8)              0.71 (0.30--1.70)       0.442
  **Smoking status^¶^**                                                                                                                  
   Never                                                   63 (32.5)                          99 (24.0)                  Reference         0.079^\#^
   Ex                                                      78 (40.2)                          189 (45.8)             0.65 (0.43--0.98)   
   Current                                                 53 (27.3)                          125 (30.3)             0.67 (0.42--1.05)   
  **Comorbidities**                                                                                                                      
   Congestive cardiac failure                              13 (6.4)                            22 (5.0)              1.30 (0.64--2.64)       0.466
   Cerebrovascular disease                                 25 (12.3)                           42 (9.6)              1.33 (0.79--2.25)       0.286
   HIV                                                      2 (1.0)                            2 (0.5)               2.18 (0.30--15.62)      0.594
   Liver disease                                            2 (1.0)                            8 (1.8)               0.54 (0.11--2.56)       0.733
   Alcohol excess                                           6 (3.0)                            16 (3.6)              0.81 (0.31--2.10)       0.659
   Chronic renal disease                                   13 (6.4)                            34 (7.7)              0.82 (0.42--1.60)       0.566
   Active malignancy                                       11 (5.4)                            27 (6.1)              0.88 (0.43--1.80)       0.720
   Chronic obstructive airway disease                      25 (12.3)                          90 (20.5)              0.55 (0.34--0.88)       0.012
   Asthma                                                  27 (13.3)                          57 (13.0)              1.03 (0.63--1.69)       0.902
   Diabetes                                                24 (11.8)                          58 (13.2)              0.88 (0.53--1.47)       0.631
   Dementia                                                 8 (3.9)                            11 (2.5)              1.60 (0.63--4.05)       0.316
  **Child contact preceding admission^¶^**                 81 (42.0)                          143 (33.7)             1.43 (1.00--2.03)       0.046
  **Pneumonia severity**                                                                                                                 
   Low (CURB65≤1)                                          80 (39.4)                          180 (40.9)                 Reference         0.746^\#^
   Moderate (CURB65=2)                                     72 (35.5)                          133 (30.2)             1.22 (0.82--1.80)   
   High (CURB65≥3)                                         51 (25.1)                          127 (28.9)             0.90 (0.59--1.37)   

Data are presented as n (%) unless stated otherwise. ^\#^: p for trend; ^¶^: smoking status and child contact data available for 607 and 618 individuals respectively.

Preceding close contact with children of any age was more strongly associated with a diagnosis of pneumococcal CAP than close contact with pre-school children \<5 years old (OR 1.84, 95% CI 1.50--2.26, p\<0.001 *versus* OR 1.52, 95% CI 1.19--1.93, p=0.001). In the multivariable model, the odds of pneumococcal CAP remained higher in those individuals admitted during school holiday periods than in those admitted during term time (adjusted OR 1.38, 95% CI 1.11--1.72, p=0.004). Other factors independently associated with an increased risk of pneumococcal CAP were younger age, smoking status of the patient, alcohol excess, COPD, increasing disease severity at admission and preceding child contact ([table 2](#TB2){ref-type="table"}). In total, 32 individuals worked with children; in a sensitivity analysis excluding these individuals, an increased effect size in the odds of pneumococcal CAP in patients admitted during the school holiday period was observed (adjusted OR 1.70, 95% CI 1.25--2.31, p=0.001). Conversely, inclusion of only those individuals without preceding child contact reduced the effect of school holidays on pneumococcal disease (adjusted OR 1.29, 95% CI 0.98--1.69, p=0.069). In a separate sensitivity analysis, exclusion of patients ≥65 years old led to an increase in the effect of school holiday periods on pneumococcal disease (adjusted OR 1.52, 95% CI 1.07--2.17, p=0.021).

###### 

Variables associated with pneumococcal community-acquired pneumonia following multivariable regression modelling of admission during school holiday periods and pneumococcal pneumonia diagnosis

                                                                                **AOR**    **95% CI**  **p-value**
  ----------------------------------------------------------------------------- --------- ------------ -------------
  **Admission during school holidays**                                          1.38       1.11--1.72  0.004
  **Age years**                                                                                        
   16--49                                                                       1.00       Reference   0.046^\#^
   50--64                                                                       0.61       0.44--0.84  
   65--74                                                                       0.70       0.50--0.97  
   75--84                                                                       0.60       0.43--0.84  
   ≥85                                                                          0.68       0.46--0.99  
  **Male**                                                                      0.70       0.57--0.86  0.001
  **Smoking history**                                                                                  
   Never                                                                        1.00       Reference   0.002^\#^
   Ex                                                                           1.21       0.93--1.58  
   Current                                                                      1.57       1.18--2.08  
  **Alcohol excess**                                                            2.47       1.26--4.85  0.009
  **Chronic obstructive airway disease**                                        0.75       0.58--0.98  0.037
  **Severity at admission (per point increase on CURB score, excluding age)**   1.63       1.44--1.84  \<0.001
  **Child contact preceding admission**                                         1.83       1.46--2.30  \<0.001

AOR: adjusted odds ratio. ^\#^: p for trend.

Of the 643 individuals with pneumococcal CAP, serotypes were obtained in 429 cases. Additional PCV-13 serotypes were the most common serotypes identified in those admitted both in school holiday periods (n=68, 50.7%) and term time (n=172, 58.3%). Serotypes not included in PCV-13 made up 24.6% (n=33) and 18.3% (n=54) of serotyped disease admitted during these respective periods (OR 1.79, 95% CI 1.15--2.80, p=0.009) ([table 3](#TB3){ref-type="table"}).

###### 

Serotypes of *Streptococcus pneumoniae* identified in adults hospitalised with community-acquired pneumonia

                                                   **School holidays**   **Term time**  **p-value**
  ----------------------------------------------- --------------------- --------------- -------------
  **Subjects**                                             134                295       
  **PCV-7 serotypes**                                   30 (22.4)          64 (21.7)    0.173
  **Additional PCV-13 serotypes**                       68 (50.7)         172 (58.3)    0.360
  **Other serotypes**                                   33 (24.6)          54 (18.3)    0.009
  **Dual serotypes**                                                                    
   Both serotypes included in PCV-13                     0 (0.0)            3 (1.0)     0.573
   One or both serotypes not included in PCV-13          3 (2.2)            2 (0.7)     0.113

Data are presented as as n (%). PCV: pneumococcal conjugate vaccine.

Over the 5-year period of the study, an overall decrease in the weekly incidence of pneumococcal CAP was observed despite seasonal spikes over the winter periods ([figure 1](#F1){ref-type="fig"}). After adjustment for age, school holiday periods were associated with an increased incidence of pneumococcal CAP requiring hospital admission (incident rate ratio (IRR) 1.35, 95% CI 1.14--1.60, p\<0.001) compared to term time.

![Weekly pneumococcal community-acquired pneumonia incidence rates over 5 years, with delineated school holiday periods by year. a) Year 1 (September 2008--2009). b) Year 2 (September 2009--2010). c) Year 3 (September 2010--2011). d) Year 4 (September 2011--2012). e) Year 5 (September 2012--2013). The blue shaded areas represent school holiday periods; unshaded areas represent term time.](00100-2016.01){#F1}

There was no difference in rates of all-cause CAP or non-pneumococcal CAP during school holidays periods (IRR 1.02, 95% CI 0.93--1.13, p=0.636 and IRR 0.90, 95% CI 0.80--1.01, p=0.087, respectively). In a sensitivity analysis, a non-significant increase in the incidence of pneumococcal CAP during the school holiday periods remained when data from the winter months were excluded (IRR 1.14, 95% CI 0.91--1.42, p=0.267).

Discussion {#s4}
==========

The main finding of this study was that individuals admitted to hospital with a diagnosis of CAP during school holiday periods were significantly more likely to report child contact prior to hospital admission and significantly more likely to have pneumococcal infection compared to adults admitted during term time. A corresponding increase in the incidence of pneumococcal CAP during school holidays was observed.

Children are the predominant nasopharyngeal carriers of *S. pneumoniae* and exposure of adults to children is a recognised risk factor for acquisition of adult pneumococcal disease \[[@C2], [@C5], [@C22], [@C23]\]. Patterns of child contact vary according to changes in human behaviour; at a population level, school holidays are major modifiers of such social patterns \[[@C18]\]. The effect of this modification of social contact patterns is reflected by corresponding changes in transmission rates of viral pathogens *via* the respiratory route, *e.g.* influenza, measles and chickenpox, in school holidays compared to term time \[[@C24]--[@C26]\].

To our knowledge, this is the first description of the impact of school holidays on the incidence of adult pneumococcal pneumonia. In an epidemiological analysis of episodes of IPD from the US Active Bacterial Core surveillance cohort, W[alter]{.smallcaps} *et al.* reported annual spikes in the incidence of IPD occurring during winter holiday periods in adults \>50 years old; the effect was most marked for the pre-PCV-7 vaccine period \[[@C27]\]. An important limitation of that analysis was the lack of individual patient data regarding child contact and the limitation to invasive disease. Other studies investigating temporal changes in pneumococcal disease have aggregated data by season and have generally confirmed the well-recognised association of increased pneumococcal infections during the winter season. However, none of these studies have isolated the effects of school holiday periods on pneumococcal disease. Our results demonstrate that whilst the effect size of school holidays on the incidence of adult pneumococcal disease was highest over the winter season, the effect was observed throughout the year over all 5 years of the study. The absence of a significant relationship between non-pneumococcal CAP and school holiday periods make it unlikely that changes in healthcare-seeking behaviour are responsible for these results.

Previous studies have found that in adults with household child contact, both IPD and nasopharyngeal carriage of *S. pneumoniae* are more likely to occur, whilst increased duration of contact with children in day care increases the odds of adult carriage \[[@C2], [@C28], [@C29]\]. We observed a significantly higher proportion of adult pneumonias due to non-PCV-13 serotypes during school holiday periods compared to term time. This may reflect a serotype shift in pneumococcal carriage in children with transmission to adults during school holidays as a result of increased child--adult contact \[[@C30]--[@C32]\].

The effect size of preceding child contact on adult pneumococcal disease was larger when preceding child contact was not restricted to young children (\<5 years old) only. This is consistent with observations demonstrating that carriage rates, whilst highest in the second to fifth years of life, can persist in 9--22% of those \>5 years old \[[@C22], [@C23], [@C33], [@C34]\].

Strengths and limitations of this analysis {#s4a}
------------------------------------------

A consistent obstacle in investigating the effect of school holidays is the variable timing of holidays, differing by year and region \[[@C35]\]. We were able to account for staggered school holiday periods over several years to accurately assess the effect on pneumococcal disease incidence in this region. Because the study hospitals covered the catchment area for emergency and acute admissions in the Greater Nottingham area, incidence rates could be calculated whilst minimising selection bias. In addition, the use of multiple laboratory techniques allowed for improved detection of noninvasive pneumococcal disease, which accounts for the vast majority of adult pneumococcal infections. Limitations of this analysis include the lack of contemporaneous data on the pneumococcal carriage state of child close contacts and on pneumococcal pneumonia occurring outside the hospital setting. Although individual patient-level data on the occurrence of child contact was a strength of this study, the duration and intensity of child contact was not measured in each instance. Unaccounted differences in the nature of child contact during school holiday periods compared to term time may therefore explain our finding of an independent association of admission during school holidays with adult pneumococcal infection despite adjustment for reported child contact. There is some suggestion that the elderly may act as a reservoir for pneumococcal infection, though strong data to support this hypothesis have not yet emerged. We were unable to explore this in our analysis because contact data with the elderly were not obtained. In addition, although we did not have data on the timing of preceding child contact, the short incubation period (1--3 days) \[[@C36]\] of *S. pneumoniae* makes it unlikely that *S. pneumoniae* acquisition occurred prior to school holidays, which had a minimum duration of 7 days. We recognise that misclassification bias may occur at the very start and end of school holiday periods; however, the size of any such misclassification was found to be very small and therefore unlikely to affect study findings (data not shown). Finally, although we examined seasonal effects on pneumococcal CAP, we did not adjust for other temporal factors, such as environmental temperature, humidity and photoperiod.

Rates of hospital admission for the management of CAP admissions are increasing over time: in the USA alone, a 96% increase in hospitalisation for pneumococcal pneumonia has been predicted by 2040 \[[@C37]\]. We have observed peaks in adult pneumococcal pneumonia during school holidays despite high infant pneumococcal vaccination coverage (by 2013, 93--96% of children in the Nottingham City and County Primary Care Trusts had received PCV vaccination by the age of 12 months) \[[@C38]\]. Further studies are required to elucidate the exact reasons for these pneumococcal peaks and, if attributable to increased transmission (child--adult or adult--adult), to identify appropriate interventions to limit such transmission.
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